The Dallas Cowboys have announced an update regarding quarterback Dak Prescott’s status. The news was made public during the team’s Week 12 matchup against the Philadelphia Eagles. The announcement provides clarity on the player’s medical condition following a recent injury.
Main News
The Dallas Cowboys announced during their Week 12 game against the Philadelphia Eagles that quarterback Dak Prescott has been diagnosed with a right calf strain. The injury occurred during the team’s previous game.
Medical imaging confirmed the nature and location of the injury. The team has stated that Prescott’s status is considered day-to-day.
The announcement did not provide a specific timeline for his return to play. Team officials have indicated they will monitor his progress throughout the week.
Summary
Dak Prescott has sustained a right calf strain, as confirmed by the Dallas Cowboys. The team made the announcement during their Week 12 contest against the Philadelphia Eagles.
The injury is being managed on a day-to-day basis. No exact date has been set for his return to game action.
The team’s medical staff will continue to evaluate his condition. Further updates are expected later in the week.
FAQs
**What is Dak Prescott’s injury?**
Dak Prescott has been diagnosed with a right calf strain. The injury was confirmed through medical testing.
What is his current status?
The Cowboys have listed Prescott as day-to-day. The team will evaluate his recovery on a daily basis.
When will he return to play?
The team has not announced a specific timeline for his return. His availability will depend on his progress in the coming days.
BreakingNews covers the latest and most impactful stories across
entertainment,
business,
sports,
politics, and
technology,
from AI breakthroughs to major global developments. Stay updated with the trends shaping our world. For news tips, editorial feedback, or professional inquiries, please email us at
[email protected].
Get the latest news first by following us on
Google News,
Twitter,
Facebook,
Telegram
, and subscribe to our
YouTube channel.
